Moleculin Biotech Inc at HC Wainwright Investment Conference - New York Transcript
Good morning, everyone, and thank you for joining the H.C. Wainwright's 25th Annual Global Investment Conference on September 11 through September 13, 2023. My name is Dr. Jade Montgomery, and I'm part of the biotechnology equity research division here at H.C. Wainwright. We're confident we are going to be able to provide value to you with over 650 companies presenting at this conference in multiple sector tracks devoted to life sciences, cryptocurrency, blockchain and fintech technology, media and telecommunications, cleantech, metals and mining, and growth.
H.C. Wainwright is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. We have a total of 26 publishing senior analysts and over 643 companies covered across all sectors. Please visit hcwco.com for more information.
(Conference Instructions) With that said, have a productive and enjoyable day. And I'd like to introduce our next presenter. I'd like to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |